GE Healthcare Advised to Restrict Omniscan in 2006
GE Healthcare Experts Restrict the Use Of Omniscan. GE Healthcare’s own experts recommended in May 2006 that it proactively restrict the use of Omniscan, a gadolinium contrast dye, after it was linked to nephrogenic systemic fibrosis (NSF). According to a ProPublica investigation, rather than take that advice, GE spent the next year … [Read more...] about GE Healthcare Advised to Restrict Omniscan in 2006
NSF Lawsuit to Go to Trial in California
Gadolinium Contrast Dye NSF Lawsuits. One of the first trials involving a gadolinium contrast dye - Magnevist - and nephrogenic systemic fibrosis (NSF) is set to begin in January. According to a report on Law.com, the outcome of the Magnevist trial could be a good indicator of how NSF plaintiffs in similar lawsuits will … [Read more...] about NSF Lawsuit to Go to Trial in California
Gadolinium Contrast Dye Risks
Gadolinium Contrast Dye Risks. A new study has found that clinicians can reduce the chances that kidney patients exposed to gadolinium contrast dyes will develop Nephrogenic Systemic Fibrosis (NSF) if they screen patients for risk factors of the disease. The study, which was conducted at the Johns Hopkins University School of … [Read more...] about Gadolinium Contrast Dye Risks
